These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 3045905)
1. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment]. Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905 [No Abstract] [Full Text] [Related]
2. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study. Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678 [No Abstract] [Full Text] [Related]
3. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain. Andersen HU; Hangaard S; Hommel E; Ridderstråle M J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286 [No Abstract] [Full Text] [Related]
4. Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapy. Moreno-Fernandez J; Chico A; Endocrinol Nutr; 2016 Dec; 63(10):571-572. PubMed ID: 27765489 [No Abstract] [Full Text] [Related]
5. To what extent can metabolism be 'normalized' in insulin-dependent diabetes? Hepp KD; Bauersachs R; Piwernetz K; Renner R Adv Second Messenger Phosphoprotein Res; 1990; 24():517-20. PubMed ID: 2119654 [No Abstract] [Full Text] [Related]
6. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off]. Moberg E Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143 [No Abstract] [Full Text] [Related]
7. Education on sensor-augmented pump use improves glucose control in type 1 diabetic patients. Thielen V; Place J; Gerbaud S; Scheen A; Bringer J; Renard E Diabetes Metab; 2010 Apr; 36(2):170-1. PubMed ID: 20153675 [No Abstract] [Full Text] [Related]
9. One year continuous run with a totally implantable insulin infusion pump in a human diabetic. Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734 [No Abstract] [Full Text] [Related]
10. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump]. Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159 [No Abstract] [Full Text] [Related]
11. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study. Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370 [TBL] [Abstract][Full Text] [Related]
12. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes. Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929 [TBL] [Abstract][Full Text] [Related]
13. [Intensive insulin therapy in the diabetic child]. Bougnères PF Union Med Can; 1985 Oct; 114(10):821-8. PubMed ID: 3909569 [No Abstract] [Full Text] [Related]
14. Clinical experience with insulin-glycerol solution in an implantable pump. Rupp WM; Rohde TD; Wigness BD; Blackshear PJ; Buchwald H Trans Am Soc Artif Intern Organs; 1983; 29():492-5. PubMed ID: 6369731 [No Abstract] [Full Text] [Related]
15. [Glycosylated hemoglobin compared with blood glucose and lipid parameters in diabetics treated with an insulin preparation and diet]. Preradov-Mikić M Med Pregl; 1987; 40(3-4):105-9. PubMed ID: 3312983 [No Abstract] [Full Text] [Related]
16. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan. Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934 [TBL] [Abstract][Full Text] [Related]
17. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus. Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525 [No Abstract] [Full Text] [Related]
18. [Treatment of type I diabetes mellitus with continuous subcutaneous insulin infusion: indications and quality control]. Berger M; Chantelau EA; Spraul M Verh Dtsch Ges Inn Med; 1989; 95():135-40. PubMed ID: 2603477 [No Abstract] [Full Text] [Related]
19. Sensor-augmented insulin-pump therapy in type 1 diabetes. Diamant M N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396 [No Abstract] [Full Text] [Related]
20. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes. Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]